{"id":"W4390545534","doi":"10.1002/pul2.12323","title":"CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial","year":2024,"lang":"en","type":"article","venue":"Pulmonary Circulation","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Abbott (Canada)","funders":"Daiichi Sankyo Europe; Duke Clinical Research Institute; St. Jude Medical; Boston Scientific Corporation; Cleveland Clinic","keywords":"Medicine; Tolerability; Pulmonary hypertension; Adverse effect; Clinical trial; Clinical endpoint; Phases of clinical research; Internal medicine; Surrogate endpoint; Pulmonary artery; Blood pressure; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005686412,0.002557902,0.001815029,0.0009352454,0.0006376958,0.001366871,0.001415555,0.002866398,0.005929973],"category_scores_gemma":[0.002857624,0.0008803806,0.001491977,0.0007056823,0.001492213,0.001234426,0.0004904327,0.003727501,0.00139454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007679595,"about_ca_system_score_gemma":0.003170397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000425793,"about_ca_topic_score_gemma":0.001042321,"domain_scores_codex":[0.9983113,0.0009376812,0.0001051467,0.0002166715,0.0002349409,0.0001942419],"domain_scores_gemma":[0.9991195,0.0001804748,0.0001709971,0.00006873254,0.0001117977,0.0003484189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7186303,0.07576673,0.002048354,0.005546597,0.001494281,0.0005799651,0.0003464237,0.003359366,0.05222567,0.003804751,0.008373175,0.1278244],"study_design_scores_gemma":[0.7098656,0.2675985,0.001662007,0.0002012499,0.0006298999,0.000191743,0.00003962743,0.001695786,0.004447945,0.000808423,0.01280357,0.00005562719],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.6877507,0.02281761,0.015303,0.007761157,0.002587175,0.2440259,0.006200044,0.0006418177,0.01291255],"genre_scores_gemma":[0.6866451,0.02228127,0.04128877,0.008916491,0.002425607,0.2225609,0.004512147,0.0001405659,0.01122916],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.005929973,"threshold_uncertainty_score":0.03007299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08435669677534527,"score_gpt":0.3459223586697776,"score_spread":0.2615656618944323,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}